OncologyInformationService
Real World Databases
Evidence based Healthcare and Market Research
logo
O.I.s) has become
TriNetX Oncology GmbH,
our new website is coming soon!

Publikation

  • Adjusted comparison of outcomes between patients from CARTITUDE-1 versus multiple myeloma patients with prior exposure to PI, IMiD and anti-CD-38 from a German registry
    Goldschmidt H., Merz M., Hari P., Agha M., Diels J., Ghilotti F., Haefliger B., C Sakabedoyan C., Bacon T., Schecter J., Jackson C., Olyslager Y., Carrasco-Alfonso MJ., Nesheiwat T., Kellermann L., Jagannath S., Poster EHA 2021 --> PDF